Schwarz Pharma's Neupro® (rotigotine Transdermal Patch) Offers Additional Benefits For Parkinson's Disease
Wed, 06 Sep 2006 03:00 PM EST
... At the 10th Congress of the European Federation of Neurological Societies (EFNS) Schwarz Pharma presented new data on Neupro® from clinical trials for patients with early and advanced stage Parkinson's disease, the results indicated that:-- Patients switched easily overnight to Neupro® from other o [click link for full article] ...
Related Topics
- Parkinson's Disease
- Testosterone Transdermal
- Fentanyl Skin Patches
- Estradiol Transdermal System
- Nicotine Skin Patches
- Lidocaine Transdermal
- Parkinson disease
- Estradiol and Norethindrone Transdermal Patch
- Ethinyl Estradiol and Norelgestromin Transdermal System
- Parkinson's Disease Medications
- Scopolamine Patch
- Deep Brain Stimulation for Parkinson's Disease
- Diseases & Conditions
- Lidocaine and Prilocaine Skin Patch
- Heart Disease
- Bone Disease
- Lung Diseases & Disorders
- Huntington's Disease
- Kidney Disease
- Rare Diseases

Not Signed In -

